{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:01:45Z","timestamp":1773673305190,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/cgt.2016.6","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T11:22:16Z","timestamp":1458300136000},"page":"98-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Adenovirus-directed expression of TIPE2 suppresses gastric cancer growth via induction of apoptosis and inhibition of AKT and ERK1\/2 signaling"],"prefix":"10.1038","volume":"23","author":[{"given":"Y","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,18]]},"reference":[{"key":"BFcgt20166_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cell.2008.03.026","volume":"133","author":"H Sun","year":"2008","unstructured":"Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 2008; 133: 415\u2013426.","journal-title":"Cell"},{"key":"BFcgt20166_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.molimm.2011.08.006","volume":"49","author":"Y Lou","year":"2011","unstructured":"Lou Y, Liu S . The TIPE (TNFAIP8) family in inflammation, immunity, and cancer. Mol Immunol 2011; 49: 4\u20137.","journal-title":"Mol Immunol"},{"key":"BFcgt20166_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cell.2008.04.017","volume":"133","author":"EC Freundt","year":"2008","unstructured":"Freundt EC, Bidere N, Lenardo MJ . A different TIPE of immune homeostasis. Cell 2008; 133: 401\u2013402.","journal-title":"Cell"},{"key":"BFcgt20166_CR4","doi-asserted-by":"publisher","first-page":"15413","DOI":"10.1073\/pnas.1204525109","volume":"109","author":"Z Wang","year":"2012","unstructured":"Wang Z, Fayngerts S, Wang P, Sun H, Johnson DS, Ruan Q et al. TIPE2 protein serves as a negative regulator of phagocytosis and oxidative burst during infection. Proc Natl Acad Sci USA 2012; 109: 15413\u201315418.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt20166_CR5","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.4049\/jimmunol.1103477","volume":"189","author":"H Sun","year":"2012","unstructured":"Sun H, Zhuang G, Chai L, Wang Z, Johnson D, Ma Y et al. TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway. J Immunol 2012; 189: 2768\u20132773.","journal-title":"J Immunol"},{"key":"BFcgt20166_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.molimm.2011.08.016","volume":"49","author":"YY Luan","year":"2011","unstructured":"Luan YY, Yao YM, Zhang L, Dong N, Zhang QH, Yu Y et al. Expression of tumor necrosis factor-alpha induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice. Mol Immunol 2011; 49: 219\u2013226.","journal-title":"Mol Immunol"},{"key":"BFcgt20166_CR7","doi-asserted-by":"publisher","first-page":"e96508","DOI":"10.1371\/journal.pone.0096508","volume":"9","author":"Y Lou","year":"2014","unstructured":"Lou Y, Zhang G, Geng M, Zhang W, Cui J, Liu S . TIPE2 negatively regulates inflammation by switching arginine metabolism from nitric oxide synthase to arginase. PLoS One 2014; 9: e96508.","journal-title":"PLoS One"},{"key":"BFcgt20166_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.clim.2009.08.014","volume":"133","author":"D Li","year":"2009","unstructured":"Li D, Song L, Fan Y, Li X, Li Y, Chen J et al. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Immunol 2009; 133: 422\u2013427.","journal-title":"Clin Immunol"},{"key":"BFcgt20166_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.molimm.2011.03.002","volume":"48","author":"W Xi","year":"2011","unstructured":"Xi W, Hu Y, Liu Y, Zhang J, Wang L, Lou Y et al. Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice. Mol Immunol 2011; 48: 1203\u20131208.","journal-title":"Mol Immunol"},{"key":"BFcgt20166_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.molimm.2014.11.019","volume":"64","author":"W Zhang","year":"2014","unstructured":"Zhang W, Zhang J, Zhao L, Shao J, Cui J, Guo C et al. TIPE2 protein negatively regulates HBV-specific CD8(+) T lymphocyte functions in humans. Mol Immunol 2014; 64: 204\u2013209.","journal-title":"Mol Immunol"},{"key":"BFcgt20166_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/sji.12110","volume":"78","author":"Y Ma","year":"2013","unstructured":"Ma Y, Liu X, Wei Z, Wang X, Wang Z, Zhong W et al. The expression and significance of TIPE2 in peripheral blood mononuclear cells from asthmatic children. Scand J Immunol 2013; 78: 523\u2013528.","journal-title":"Scand J Immunol"},{"key":"BFcgt20166_CR12","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.4049\/jimmunol.1300053","volume":"191","author":"Y Lou","year":"2013","unstructured":"Lou Y, Liu S, Zhang C, Zhang G, Li J, Ni M et al. Enhanced atherosclerosis in TIPE2-deficient mice is associated with increased macrophage responses to oxidized low-density lipoprotein. J Immunol 2013; 191: 4849\u20134857.","journal-title":"J Immunol"},{"key":"BFcgt20166_CR13","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.4049\/jimmunol.1400415","volume":"193","author":"Y Lou","year":"2014","unstructured":"Lou Y, Sun H, Morrissey S, Porturas T, Liu S, Hua X et al. Critical roles of TIPE2 protein in murine experimental colitis. J Immunol 2014; 193: 1064\u20131070.","journal-title":"J Immunol"},{"key":"BFcgt20166_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2012.01.006","volume":"45","author":"Y Gus-Brautbar","year":"2012","unstructured":"Gus-Brautbar Y, Johnson D, Zhang L, Sun H, Wang P, Zhang S et al. The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell 2012; 45: 610\u2013618.","journal-title":"Mol Cell"},{"key":"BFcgt20166_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1476-4598-12-149","volume":"12","author":"X Cao","year":"2013","unstructured":"Cao X, Zhang L, Shi Y, Sun Y, Dai S, Guo C et al. Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1. Mol Cancer 2013; 12: 149.","journal-title":"Mol Cancer"},{"key":"BFcgt20166_CR16","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/jcb.25068","volume":"116","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Zhao M, Dong T, Zhou C, Peng Y, Zhou X et al. Tumor necrosis factor-alpha-induced protein-8 like-2 (TIPE2) upregulates p27 to decrease gastic cancer cell proliferation. J Cell Biochem 2015; 116: 1121\u20131129.","journal-title":"J Cell Biochem"},{"key":"BFcgt20166_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bbrc.2014.12.080","volume":"457","author":"Y Li","year":"2015","unstructured":"Li Y, Li X, Liu G, Sun R, Wang L, Wang J et al. Downregulated TIPE2 is associated with poor prognosis and promotes cell proliferation in non-small cell lung cancer. Biochem Biophys Res Commun 2015; 457: 43\u201349.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcgt20166_CR18","doi-asserted-by":"publisher","first-page":"e0126176","DOI":"10.1371\/journal.pone.0126176","volume":"10","author":"QQ Liu","year":"2015","unstructured":"Liu QQ, Zhang FF, Wang F, Qiu JH, Luo CH, Zhu GY et al. TIPE2 inhibits lung cancer growth attributing to promotion of apoptosis by regulating some apoptotic molecules expression. PLoS One 2015; 10: e0126176.","journal-title":"PLoS One"},{"key":"BFcgt20166_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3233\/CBM-140402","volume":"14","author":"XM Li","year":"2014","unstructured":"Li XM, Su JR, Yan SP, Cheng ZL, Yang TT, Zhu Q . A novel inflammatory regulator TIPE2 inhibits TLR4-mediated development of colon cancer via caspase-8. Cancer Biomark 2014; 14: 233\u2013240.","journal-title":"Cancer Biomark"},{"key":"BFcgt20166_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3892\/ol.2013.1388","volume":"6","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Qi H, Hou S, Jin X . TIPE2 mRNA overexpression correlates with TNM staging in renal cell carcinoma tissues. Oncol Lett 2013; 6: 571\u2013575.","journal-title":"Oncol Lett"},{"key":"BFcgt20166_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"BFcgt20166_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1535-6108(04)00033-9","volume":"5","author":"T Ushijima","year":"2004","unstructured":"Ushijima T, Sasako M . Focus on gastric cancer. Cancer Cell 2004; 5: 121\u2013125.","journal-title":"Cancer Cell"},{"key":"BFcgt20166_CR23","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","volume":"95","author":"TC He","year":"1998","unstructured":"He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B . A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509\u20132514.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt20166_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1089\/1043034041361181","volume":"15","author":"Y Liu","year":"2004","unstructured":"Liu Y, Ye T, Sun D, Maynard J, Deisseroth A . Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma. Hum Gene Ther 2004; 15: 637\u2013647.","journal-title":"Hum Gene Ther"},{"key":"BFcgt20166_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/cgt.2010.67","volume":"18","author":"Y Xie","year":"2011","unstructured":"Xie Y, Sheng W, Miao J, Xiang J, Yang J . Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells. Cancer Gene Ther 2011; 18: 176\u2013188.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt20166_CR26","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.molimm.2010.06.016","volume":"47","author":"G Zhang","year":"2010","unstructured":"Zhang G, Hao C, Lou Y, Xi W, Wang X, Wang Y et al. Tissue-specific expression of TIPE2 provides insights into its function. Mol Immunol 2010; 47: 2435\u20132442.","journal-title":"Mol Immunol"},{"key":"BFcgt20166_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1232227","volume":"339","author":"LM Coussens","year":"2013","unstructured":"Coussens LM, Zitvogel L, Palucka AK . Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 2013; 339: 286\u2013291.","journal-title":"Science"},{"key":"BFcgt20166_CR28","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.molimm.2011.03.001","volume":"48","author":"L Zhang","year":"2011","unstructured":"Zhang L, Shi Y, Wang Y, Zhu F, Wang Q, Ma C et al. The unique expression profile of human TIPE2 suggests new functions beyond its role in immune regulation. Mol Immunol 2011; 48: 1209\u20131215.","journal-title":"Mol Immunol"},{"key":"BFcgt20166_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.18632\/oncotarget.240","volume":"2","author":"WH Chappell","year":"2011","unstructured":"Chappell WH, Steelman LS, Long JM, Kempf RC, Abrams SL, Franklin RA et al. Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 2011; 2: 135\u2013164.","journal-title":"Oncotarget"},{"key":"BFcgt20166_CR30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ctrv.2013.03.009","volume":"39","author":"KS Saini","year":"2013","unstructured":"Saini KS, Loi S, de Azambuja E, Metzger-Filho O, Saini ML, Ignatiadis M et al. Targeting the PI3K\/AKT\/mTOR and Raf\/MEK\/ERK pathways in the treatment of breast cancer. Cancer Treat Rev 2013; 39: 935\u2013946.","journal-title":"Cancer Treat Rev"},{"key":"BFcgt20166_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fonc.2014.00064","volume":"4","author":"C Porta","year":"2014","unstructured":"Porta C, Paglino C, Mosca A . Targeting PI3K\/Akt\/mTOR signaling in cancer. Front Oncol 2014; 4: 64.","journal-title":"Front Oncol"},{"key":"BFcgt20166_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4161\/cc.23325","volume":"12","author":"G Zhang","year":"2013","unstructured":"Zhang G, Zhang W, Lou Y, Xi W, Cui J, Geng M et al. TIPE2 deficiency accelerates neointima formation by downregulating smooth muscle cell differentiation. Cell Cycle 2013; 12: 501\u2013510.","journal-title":"Cell Cycle"},{"key":"BFcgt20166_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3892\/ijo.2014.2725","volume":"46","author":"YH Zhang","year":"2015","unstructured":"Zhang YH, Yan HQ, Wang F, Wang YY, Jiang YN, Wang YN et al. TIPE2 inhibits TNF-alpha-induced hepatocellular carcinoma cell metastasis via Erk1\/2 downregulation and NF-kappaB activation. Int J Oncol 2015; 46: 254\u2013264.","journal-title":"Int J Oncol"},{"key":"BFcgt20166_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial NN, Korsmeyer SJ . Cell death: critical control points. Cell 2004; 116: 205\u2013219.","journal-title":"Cell"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt20166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt20166","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt20166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:03:41Z","timestamp":1647950621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt20166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,18]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFcgt20166"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2016.6","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,18]]},"assertion":[{"value":"15 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}